Lak activity potentiator orginating in shitake mushroom...

Drug – bio-affecting and body treating compositions – Extract or material containing or obtained from a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S439000, C424S442000, C435S254100

Reexamination Certificate

active

06919081

ABSTRACT:
It is an object of the present invention to provide immunopotentiators and immunotherapeutic formulations available at low cost and having a benign side effect profile. According to the present invention, an LAK activity enhancer containing an extract of Lentinus edodes mycelium and an LAK activity-enhancing formulation containing said enhancer are provided.

REFERENCES:
patent: 4461760 (1984-07-01), Sugano et al.
patent: 2004/0038330 (2004-02-01), Nagaoka
patent: 7-173070 (1995-07-01), None
patent: 2000-159686 (2000-06-01), None
Anticancer Research, vol. 13, No. 5c, p1773-1776, 1993 “Augmentation of Lymaphpkine-Activated Killer Cell Activity by Lentinan” Masaji Tani et al, p1776.
International Journal of Immunopharmacology, vol. 14, no4, p. 535-539, 1992 “Enhanced Induction of Lymphokine-Activated Killer Activity After Lentinan Administration in Patients with Gastric Carcinma” Shinya Arinaga et al, See p. 535, right column, lines 1-3.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Lak activity potentiator orginating in shitake mushroom... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lak activity potentiator orginating in shitake mushroom..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lak activity potentiator orginating in shitake mushroom... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3424440

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.